Wednesday
March 5, 2025
8:44 AM ET
Market News Alert: Nuvectis Pharma’s NXP900 Demonstrates Superior Efficacy in NSCLC When Combined with Tagrisso in Cleveland Clinic Study, Following New Buy Recommendation
Tuesday
February 25, 2025
8:00 AM ET
Nuvectis Pharma, Inc. Reports 2024 Financial Results and Business Highlights
Tuesday
November 5, 2024
7:00 AM ET
Nuvectis Pharma, Inc. Reports Third Quarter 2024 Financial Results and Business Highlights